In vitro cell culture is a key research tool for simulating human development and disease. Although traditional monolayer cell cultures were once widely used, these models lack the tissue architecture and complexity necessary to elucidate authentic biological processes occurring in vivo. However, recent advances in organoid technology have transformed in vitro cultivation tools for biomedical research by creating robust three-dimensional (3D) models that replicate the cellular heterogeneity, structure and function of primary tissues. This technology allows researchers to recreate human organs and disease states in laboratory dishes, demonstrating its immense potential for translational applications in areas such as regenerative medicine, drug development and precision medicine.

Organoids can be derived from embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs) or adult stem cells (ASCs) through processes analogous to organ formation, yielding their unique tissue architecture. Self-organization within organoids is achieved through spatially constrained lineage differentiation and cell sorting, which requires the activation of multiple signalling pathways. These pathways are mediated by intrinsic cellular components or extrinsic environments, such as the extracellular matrix and the culture medium.

Indeed, organoid technology has evolved to include other animal species beyond mouse and human models. Studies have reported the successful establishment of intestinal, mammary, keratinocyte and hepatic organoids in various species, including cattle, pigs, sheep, chickens, cats and dogs. Furthermore, recent research has achieved the preparation of snake venom gland organoids capable of high-level expression of toxin transcripts, offering potential applications in toxicological studies.

Creative Diagnostics has developed a comprehensive range of normal tissue- and tumor-derived organoid models, and reagents for organoid culture and differentiation. The company also offers customized services, including organoid model establishment, drug screening, toxicological assessments, and cell therapy evaluations. By introducing the Normal Tissue-derived Organoid Culture Kits, Creative Diagnostics is helping researchers to establish the necessary control and baseline models to precisely measure therapeutic effect and toxicity. 

This new product line includes various specialized systems, such as Human Normal Colorectal Organoid Culture Kits and Human Normal Epidermal Organoid Culture Kits, which can support tissue-specific differentiation and long-term viability. The Human Normal Colorectal Organoid Culture Kit (NOGNCK-IP250407), for example, offers an optimized, efficient, and stable solution for the culture of human normal colorectal organoids. These kits can ensure reliable and reproducible organoid generation across various research laboratories.

The Normal Tissue-derived Organoid Culture Kits are available to researchers worldwide for use in biomedical studies, precision medicine, toxicology studies, and regenerative medicine. To learn more about the new kits, please visit https://qbd.creative-diagnostics.com/products/ogn-normal-tissue-derived-organoid-culture-kit.html.

About Creative Diagnostics

Creative Diagnostics is a global leader in the development and manufacturing of innovative tools and reagents for bioprocess impurity analysis. The company offers a comprehensive portfolio of solutions to support researchers in the quality control of biologics and provides biopharmaceutical quality, purity and safety assays, analytical methods and applications for the biotechnology and biopharmaceutical industries.